Skip to content

To assess the efficacy of Serratus anterior plane block to provide pain relief after breast surgery

a prospective randomized study to assess the analgesic efficacy of serratus anterior plane ( SA P) block for modified radical mastectomy under general anaesthesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010424
Enrollment
100
Registered
2017-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- CARCINOMA BREAST

Interventions

Intervention1: Group S: Modified radical mastectomy under general anaestheisa along with SAP block using 0.4ml/kg of 0.375% Ropivacaine(with a maximum volume of 30ml) Control Intervention1: NIL: N

Sponsors

AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American society of anesthesiologistâ??s (ASA) physical status (PS) I and II undergoing modified radical mastectomy will be recruited in this study.

Exclusion criteria

Exclusion criteria: 1. Unwilling patients 2. Patients with infection at the site of SAPblock. 3. Patient withsevere chest wall deformity. 4. Patient with BMI >=30kg/m2. 5. Patients with history suggestive of coagulopathy or receiving any anticoagulants

Design outcomes

Primary

MeasureTime frame
Time to first rescue analgesic in the post-operative period in women undergoing modified radical mastectomy under general anaesthesia with and without SAP block.Timepoint: Pain assessment will be done in the immediate postoperative period after shifting the patient to PACU(time zero) and thereafter at 1, 2, 6, 12 and 24 hours.

Secondary

MeasureTime frame
â?¢ Total intraoperative fentanyl consumption among the two groups. â?¢ Total doses of diclofenac consumed in the post operative period in 24 hours. â?¢ Total tramadol consumption in mg in the post operative period in 24 hours. â?¢ Postoperative nausea and vomiting Timepoint: Nausea and vomiting will be measured at 0, 1, 2, 6, 12 and 24 hours and whenever the patient complains of nausea/vomiting

Countries

India

Contacts

Public ContactDr Swati Bhan

DrBRAIRCH, AIIMS

seemamishra2003@gmail.com9899061105

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 17, 2026